DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
US5788962A · kind A · utility
17Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 28, 1996 |
| Grant date | Aug 4, 1998 |
| Priority date | — |
| Expiry date | Aug 28, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Mycoplasma hyopneumoniae P65 surface antigens prepared by recombinant DNA or synthetic methods, protein antigens encoded by P65 gene, an expression vector and transformed host containing the antigens, a vaccine based on such antigens, methods of treating swine, etc. to prevent enzootic pneumonia using that vaccine and diagnostic tests to detect the presence of Mycoplasma hyopneumoniae.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.